Yuval Cohen

CIK: 0001626003

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)5 (55.6%)

Position reduction

Option Exercises (M)2 (22.2%)

Derivative conversions

Awards (A)2 (22.2%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

CRBP

Corbus Pharmaceuticals Holdings, Inc.

DirectorOfficer

Discretionary Trading P&L

Holdings

Transaction History (9 total)

CRBP
Corbus Pharmaceuticals Holdings, Inc.
Aug 7, 2026
Sale(S)
Direct
17K shares at avg. $10.08$171K
CRBP
Corbus Pharmaceuticals Holdings, Inc.
Feb 13, 2026
Sale(S)
Direct
13.9K shares at avg. $7.78$108K
CRBP
Corbus Pharmaceuticals Holdings, Inc.
Jan 14, 2026
Award(A)
Direct
50K shares-
CRBP
Corbus Pharmaceuticals Holdings, Inc.
Oct 27, 2025
Exercise(M)
Direct
9K shares at avg. $4.26$38K
CRBP
Corbus Pharmaceuticals Holdings, Inc.
Oct 27, 2025
Sale(S)
Direct
9K shares at avg. $17.14$154K
CRBP
Corbus Pharmaceuticals Holdings, Inc.
Oct 24, 2025
Sale(S)
Direct
18.7K shares at avg. $17.01$317K
CRBP
Corbus Pharmaceuticals Holdings, Inc.
Oct 24, 2025
Exercise(M)
Direct
18.7K shares at avg. $4.26$79K
CRBP
Corbus Pharmaceuticals Holdings, Inc.
Feb 14, 2025
Sale(S)
Direct
7.1K shares at avg. $8.76$62K
CRBP
Corbus Pharmaceuticals Holdings, Inc.
Jan 31, 2025
Award(A)
Direct
68.1K shares-

		Type	Shares	Price		Ownership
Aug 7, 2026	CRBP Corbus Pharmaceuticals Holdings, Inc.	Sale(S)	17,000	$10.08	$171,396	Direct
Feb 13, 2026	CRBP Corbus Pharmaceuticals Holdings, Inc.	Sale(S)	13,871	$7.78	$107,952	Direct
Jan 14, 2026	CRBP Corbus Pharmaceuticals Holdings, Inc.	Award(A)	50,000	-	$0	Direct
Oct 27, 2025	CRBP Corbus Pharmaceuticals Holdings, Inc.	Exercise(M)	8,973	$4.26	$38,225	Direct
Oct 27, 2025	CRBP Corbus Pharmaceuticals Holdings, Inc.	Sale(S)	8,973	$17.14	$153,797	Direct
Oct 24, 2025	CRBP Corbus Pharmaceuticals Holdings, Inc.	Sale(S)	18,660	$17.01	$317,407	Direct
Oct 24, 2025	CRBP Corbus Pharmaceuticals Holdings, Inc.	Exercise(M)	18,660	$4.26	$79,492	Direct
Feb 14, 2025	CRBP Corbus Pharmaceuticals Holdings, Inc.	Sale(S)	7,134	$8.76	$62,465	Direct
Jan 31, 2025	CRBP Corbus Pharmaceuticals Holdings, Inc.	Award(A)	68,100	-	-	Direct

1-9 of 9 transactions

About Cohen Yuval

Cohen Yuval (SEC CIK 0001626003) files insider reports with the SEC as Chief Executive Officer of Corbus Pharmaceuticals Holdings, Inc. (CRBP).

Signal8 holds 6 ownership filings by Cohen Yuval, all Form 4s, filed between Feb 4, 2025 and Aug 10, 2026. Those filings report 9 transactions, from Jan 31, 2025 to Aug 7, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Cohen Yuval's filings is in NORWOOD, MA.

Recent filings by Cohen Yuval

Aug 7, 2026: Open-market sale of CRBP shares (Form 4, code S).
Feb 13, 2026: Open-market sale of CRBP shares (Form 4, code S).
Jan 14, 2026: Grant or award of CRBP shares (Form 4, code A).
Oct 27, 2025: Option exercise of CRBP shares (Form 4, code M).
Oct 27, 2025: Open-market sale of CRBP shares (Form 4, code S).

Other insiders filing for Corbus Pharmaceuticals Holdings, Inc. (CRBP)

Cormorant Asset Management, LP, Officer
Ben Yong, Director
Nicacio Leonardo Viana, Chief Medical Officer
Saxena Nishant C, Chief Business Officer
Moran Sean F., Chief Financial Officer
Kung Winston, Director

How to read Form 4 transaction codes